Fig. 4.
Proportion of patients who developed migraine-like attacks and headache after CGRP and placebo. More patients developed migraine-like attacks after CGRP (n = 10), compared to placebo (n = 0) (p = 0.002)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.